Vimarsana
Biggest News Aggregation in the World

Page 13 - Cue Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cue Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cue Test Today - Breaking & Trending Today

CNN CNN Newsroom With Pamela Brown March 27, 2022 02:49:00 - Vimarsana News

CNN CNN Newsroom With Pamela Brown March 27, 2022 02:49:00

Seven hundred and thirty dollars. (customer) that's something. (burke) get a whole lot of something with farmers. ♪we are farmers.bum-pa-dum, bum-bum-bum-bum♪ andy, justin tested positive. let's do a cue test. okay. ♪ (whispers) whoa, what is that? ♪ who is this new device? i'm cue and i'm here to protect the family. hey, that's my job. i'm a smart home testing lab. i'm fast and super accurate. please be negative. don't worry, i got this. woah! shhh, they're coming... ♪ yesss! we're really warming up to you, cue. just wait till you see what else i can do.

Cue Health Launches 'Cue for Schools,' an On-Site Molecular Testing Solution for K-12 and Universities - Vimarsana News

Cue Health Launches 'Cue for Schools,' an On-Site Molecular Testing Solution for K-12 and Universities

Share this article Share this article SAN DIEGO, April 5, 2021 /PRNewswire/ -- Cue Health Inc. ("Cue"), a healthcare technology company, today announced "Cue for Schools," a COVID-19 on-site testing solution for K-12 schools and universities that uses the Cue Health Monitoring System and the Cue COVID-19 Test for Home and Over The Counter (OTC) Use, the nation's first molecular diagnostic test available without a prescription with Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). Cue's easy-to-use, portable COVID-19 test provides lab-quality results directly...

FDA Authorizes Cue Health's COVID-19 Test for At-Home and Over The Counter Use - Vimarsana News

FDA Authorizes Cue Health's COVID-19 Test for At-Home and Over The Counter Use

Share this article Share this article SAN DIEGO, March 5, 2021 /PRNewswire/ -- Cue Health Inc. (Cue) announced the healthcare technology company has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for over the counter sale of its fast, accurate, COVID-19 test, making it the nation's first molecular diagnostic test available to consumers without a prescription. The Cue COVID-19 Test for Home and Over The Counter (OTC) Use (Cue OTC Test) uses a lower nasal swab and delivers results in about 20 minutes to the user's mobile smart device. The Cue OTC Tes...

Cue Receives CE Mark for Its Molecular Point-of-Care COVID-19 Test - Vimarsana News

Cue Receives CE Mark for Its Molecular Point-of-Care COVID-19 Test

Share this article Share this article SAN DIEGO, Feb. 23, 2021 /PRNewswire/ -- Cue Health Inc. (Cue), a healthcare technology company, today announced its molecular point-of-care COVID-19 Test has received the CE mark, clearing it for sale and distribution in the European Union (EU). The Cue COVID-19 Test is a highly sensitive and specific nucleic acid amplification test (NAAT) that runs on the Cue Health Monitoring System, displaying test results directly on a connected mobile smart device in about 20 minutes via the Cue Health App. The Cue COVID-19 Test consists of the Cue Test Cartridge, ...

Cue Health's Connected Point-of-Care COVID-19 Test Demonstrates 97.8% Agreement When Compared to Central Lab PCR Testing in an Independent Clinical Validation Study - Vimarsana News

Cue Health's Connected Point-of-Care COVID-19 Test Demonstrates 97.8% Agreement When Compared to Central Lab PCR Testing in an Independent Clinical Validation Study

Share this article Share this article SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- Cue Health Inc. (Cue) announced today the results of an independent clinical validation study conducted by Mayo Clinic Laboratories evaluating the accuracy of Cue's COVID-19 Test in the point-of-care setting against the centralized lab PCR testing model. The study, which was published in Diagnostic Microbiology and Infectious Diseases, included samples from 292 patients at a collection site operated by the Mayo Clinic Health System. The study found that the overall concordance between the Cue point-of-care test an...